Lymphomas and Lymphoproliferative Disorders: From Diagnosis to Treatment
Topic Information
Dear Colleagues,
The diagnosis and treatment of lymphoma has been significantly advanced by the appearance of biomarkers and molecular targeted drugs. Lymphoproliferative disorders consist of a wide spectrum between polyclonal and monoclonal lymphoid proliferation, i.e., including benign lymphoid lesions to lymphomas. Lymphoproliferative disorders, benign lymphoid lesions in particular, and their etiology and pathogenesis are still unknown, and pathological diagnosis has not been established in many disorders.
This Topic will highlight recent advances and knowledge acquired in lymphomas and lymphoproliferative disorders aspects of clinical and pathological findings, pathogenesis, as well as treatment strategy. Research revealing negative results is also welcome. We seek expert research articles, review articles, and case reports on recent advances in lymphomas and lymphoproliferative disorders, including future perspectives/directions.
Prof. Dr. Yasuharu Sato
Dr. Midori Filiz Nishimura
Dr. Yoshito Nishimura
Topic Editors
Keywords
- lymphomas
- lymphoproliferative disorders
- clinical characteristics
- pathological characteristics
- molecular pathology
- pathogenesis
- treatment strategy
Participating Journals
38,000 Articles
Launched in 2009
4.8Impact Factor
9.0CiteScore
18 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
20,840 Articles
Launched in 2011
3.8Impact Factor
6.9CiteScore
20 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q1Highest JCR Category Ranking
116,238 Articles
Launched in 2000
5.6Impact Factor
10.0CiteScore
18 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q1Highest JCR Category Ranking
54,425 Articles
Launched in 2012
3.3Impact Factor
5.2CiteScore
17 DaysSubmission to First Decision
3 DaysAcceptance to Publication
Q1Highest JCR Category Ranking
202 Articles
Launched in 2020
2.5Impact Factor
2.7CiteScore
28 DaysSubmission to First Decision
6 DaysAcceptance to Publication
Q2Highest JCR Category Ranking
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
i. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
ii. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
iii. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
iv. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
v. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.